Dr Reddys Laboratories Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 0.60 | (8.80) | 3.63 | 12 |
| Op profit growth | (4.90) | (31) | 2.62 | 7.47 |
| EBIT growth | (12) | (45) | (2.20) | 8.47 |
| Net profit growth | (27) | (39) | (8.80) | 19 |
| Profitability ratios (%) | ||||
| OPM | 16.50 | 17.40 | 23 | 23.30 |
| EBIT margin | 10 | 11.40 | 18.90 | 20 |
| Net profit margin | 6.63 | 9.10 | 13.70 | 15.60 |
| RoCE | 8.12 | 9.71 | 19.40 | 22.50 |
| RoNW | 1.91 | 2.60 | 4.75 | 6.59 |
| RoA | 1.35 | 1.94 | 3.52 | 4.36 |
| Per share ratios () | ||||
| EPS | 55 | 75.80 | 124 | 133 |
| Dividend per share | 20 | 20 | 20 | 20 |
| Cash EPS | (7.90) | 16 | 69.90 | 92.50 |
| Book value per share | 758 | 740 | 737 | 578 |
| Valuation ratios | ||||
| P/E | 37.90 | 34.70 | 24.60 | 26.20 |
| P/CEPS | (265) | 164 | 43.40 | 37.70 |
| P/B | 2.75 | 3.56 | 4.12 | 6.03 |
| EV/EBIDTA | 15.70 | 18.20 | 14.10 | 16.40 |
| Payout (%) | ||||
| Dividend payout | 35 | 25.70 | 19.30 | 17.60 |
| Tax payout | (32) | (19) | (26) | (19) |
| Liquidity ratios | ||||
| Debtor days | 100 | 102 | 96.40 | 90.20 |
| Inventory days | 73.60 | 69.60 | 60.10 | 60.60 |
| Creditor days | (45) | (40) | (35) | (34) |
| Leverage ratios | ||||
| Interest coverage | (18) | (26) | (36) | (28) |
| Net debt / equity | 0.38 | 0.37 | 0.23 | 0.25 |
| Net debt / op. profit | 2.04 | 1.83 | 0.80 | 0.70 |
| Cost breakup () | ||||
| Material costs | (28) | (26) | (24) | (25) |
| Employee costs | (23) | (22) | (20) | (20) |
| Other costs | (33) | (35) | (33) | (32) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Revenue | 14,281 | 14,196 | 15,568 | 15,023 |
| yoy growth (%) | 0.60 | (8.80) | 3.63 | 12 |
| Raw materials | (4,040) | (3,697) | (3,759) | (3,786) |
| As % of sales | 28.30 | 26 | 24.10 | 25.20 |
| Employee costs | (3,215) | (3,107) | (3,117) | (2,945) |
| As % of sales | 22.50 | 21.90 | 20 | 19.60 |
| Other costs | (4,675) | (4,921) | (5,107) | (4,799) |
| As % of sales | 32.70 | 34.70 | 32.80 | 31.90 |
| Operating profit | 2,351 | 2,472 | 3,585 | 3,494 |
| OPM | 16.50 | 17.40 | 23 | 23.30 |
| Depreciation | (1,077) | (1,027) | (939) | (760) |
| Interest expense | (79) | (63) | (83) | (108) |
| Other income | 155 | 172 | 295 | 274 |
| Profit before tax | 1,350 | 1,554 | 2,859 | 2,900 |
| Taxes | (438) | (297) | (751) | (563) |
| Tax rate | (32) | (19) | (26) | (19) |
| Minorities and other | 34.40 | 34.90 | 22.90 | -- |
| Adj. profit | 947 | 1,292 | 2,131 | 2,336 |
| Exceptional items | -- | -- | -- | -- |
| Net profit | 947 | 1,292 | 2,131 | 2,336 |
| yoy growth (%) | (27) | (39) | (8.80) | 19 |
| NPM | 6.63 | 9.10 | 13.70 | 15.60 |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Profit before tax | 1,350 | 1,554 | 2,859 | 2,900 |
| Depreciation | (1,077) | (1,027) | (939) | (760) |
| Tax paid | (438) | (297) | (751) | (563) |
| Working capital | 1,894 | 418 | (861) | (35) |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | 1,729 | 648 | 308 | 1,542 |
| Capital expenditure | 9,461 | 7,090 | 4,930 | 656 |
| Free cash flow | 11,191 | 7,738 | 5,238 | 2,198 |
| Equity raised | 15,819 | 16,121 | 17,049 | 15,553 |
| Investments | 2,297 | 1,902 | 3,636 | 1,181 |
| Debt financing/disposal | 7,386 | 8,085 | 6,858 | 8,582 |
| Dividends paid | 332 | 331 | 411 | 341 |
| Other items | -- | -- | -- | -- |
| Net in cash | 37,025 | 34,177 | 33,192 | 27,854 |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Equity capital | 29.50 | 83 | 82.90 | 85.30 |
| Preference capital | -- | -- | -- | -- |
| Reserves | 13,994 | 12,489 | 12,179 | 12,485 |
| Net worth | 14,024 | 12,572 | 12,262 | 12,570 |
| Minority interest | ||||
| Debt | 3,838 | 5,071 | 4,919 | 3,352 |
| Deferred tax liabilities (net) | 47.30 | 195 | 162 | 53.70 |
| Total liabilities | 17,909 | 17,838 | 17,343 | 15,976 |
| Fixed assets | 10,125 | 10,439 | 10,255 | 7,335 |
| Intangible assets | ||||
| Investments | 2,587 | 2,298 | 2,110 | 3,833 |
| Deferred tax asset (net) | 432 | 541 | 678 | 591 |
| Net working capital | 4,543 | 4,297 | 3,913 | 3,725 |
| Inventories | 3,358 | 2,909 | 2,853 | 2,558 |
| Inventory Days | -- | 74.30 | 73.30 | 60 |
| Sundry debtors | 3,987 | 4,053 | 3,799 | 4,125 |
| Debtor days | -- | 104 | 97.70 | 96.70 |
| Other current assets | 1,755 | 2,042 | 1,735 | 1,450 |
| Sundry creditors | (1,455) | (1,607) | (1,342) | (1,230) |
| Creditor days | -- | 41.10 | 34.50 | 28.80 |
| Other current liabilities | (3,101) | (3,100) | (3,132) | (3,179) |
| Cash | 223 | 264 | 387 | 492 |
| Total assets | 17,909 | 17,838 | 17,343 | 15,976 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Mar-2020 | Dec-2019 | Sep-2019 | Jun-2019 | Mar-2019 |
|---|---|---|---|---|---|
| Gross Sales | 4,432 | 4,384 | 4,801 | 3,844 | 4,017 |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | 4,432 | 4,384 | 4,801 | 3,844 | 4,017 |
| Other Operating Income | 17.10 | 13.30 | 12 | 14.60 | 13 |
| Other Income | 84.10 | 84.90 | 65.70 | 446 | 99 |
| Total Income | 4,533 | 4,482 | 4,879 | 4,305 | 4,129 |
| Total Expenditure ** | 3,500 | 4,686 | 3,749 | 3,117 | 3,211 |
| PBIDT | 1,033 | (204) | 1,130 | 1,188 | 918 |
| Interest | 23 | 15.20 | 30.30 | 29.80 | 24.50 |
| PBDT | 1,010 | (219) | 1,099 | 1,158 | 893 |
| Depreciation | 274 | 287 | 313 | 289 | 287 |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | 41.70 | 174 | 211 | 236 | 141 |
| Deferred Tax | (87) | (141) | (532) | (43) | 9.50 |
| Reported Profit After Tax | 781 | (538) | 1,107 | 677 | 455 |
| Minority Interest After NP | -- | -- | -- | -- | -- |
| Net Profit after Minority Interest | 781 | (538) | 1,107 | 677 | 455 |
| Extra-ordinary Items | -- | -- | -- | -- | -- |
| Adjusted Profit After Extra-ordinary item | 781 | (538) | 1,107 | 677 | 455 |
| EPS (Unit Curr.) | 47.10 | (32) | 66.80 | 40.80 | 27.50 |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | -- | -- | -- | -- |
| Equity | 83.10 | 83.10 | 83.10 | 83.10 | 83 |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | 23.30 | (4.60) | 23.50 | 30.90 | 22.90 |
| PBDTM(%) | 22.80 | (5) | 22.90 | 30.10 | 22.20 |
| PATM(%) | 17.60 | (12) | 23.10 | 17.60 | 11.30 |
